Opko Health Inc (NASDAQ: OPK) on Monday, plunged -0.68% from the previous trading day, before settling in for the closing price of $1.48. Within the past 52 weeks, OPK’s price has moved between $0.85 and $1.76.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 3.29% annually for the last half of the decade. The company achieved an average annual earnings per share of 12.00%. With a float of $309.23 million, this company’s outstanding shares have now reached $682.48 million.
In an organization with 3930 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 16.19%, operating margin of -26.43%, and the pretax margin is -16.57%.
Opko Health Inc (OPK) Insider Updates
Observing investor behavior towards Diagnostics & Research industry stocks is more important than anything else. The insider ownership of Opko Health Inc is 54.69%, while institutional ownership is 30.36%. The most recent insider transaction that took place on Dec 13 ’24, was worth 199,375. In this transaction CEO & Chairman of this company bought 125,000 shares at a rate of $1.59, taking the stock ownership to the 212,536,477 shares. Before that another transaction happened on Dec 11 ’24, when Company’s CEO & Chairman bought 500,000 for $1.56, making the entire transaction worth $781,050. This insider now owns 212,411,477 shares in total.
Opko Health Inc (OPK) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.00% during the next five years compared to 1.56% growth over the previous five years of trading.
Opko Health Inc (NASDAQ: OPK) Trading Performance Indicators
Opko Health Inc (OPK) is currently performing well based on its current performance indicators. A quick ratio of 2.69 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.41.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.19, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.29 in one year’s time.
Technical Analysis of Opko Health Inc (OPK)
Let’s dig in a bit further. During the last 5-days, its volume was 2.13 million. That was inferior than the volume of 6.68 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 15.01%. Additionally, its Average True Range was 0.07.
During the past 100 days, Opko Health Inc’s (OPK) raw stochastic average was set at 27.50%, which indicates a significant increase from 12.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 23.55% in the past 14 days, which was lower than the 40.19% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5424, while its 200-day Moving Average is $1.4136. However, in the short run, Opko Health Inc’s stock first resistance to watch stands at $1.4900. Second resistance stands at $1.5100. The third major resistance level sits at $1.5400. If the price goes on to break the first support level at $1.4400, it is likely to go to the next support level at $1.4100. Assuming the price breaks the second support level, the third support level stands at $1.3900.
Opko Health Inc (NASDAQ: OPK) Key Stats
Market capitalization of the company is 1.00 billion based on 682,483K outstanding shares. Right now, sales total 863,500 K and income totals -188,860 K. The company made 173,630 K in profit during its latest quarter, and 24,890 K in sales during its previous quarter.
